Preferences and Attitudes of Cardiologists in Management of Patients with Cancer
Ibrahim Azar(Wayne State University), Joshua Schulman‐Marcus(Albany Medical Center Hospital), Hirva Mamdani(Wayne State University), Michael Stellini(The Barbara Ann Karmanos Cancer Institute), Jacqueline Kenitz(Albany Medical Center Hospital), Dawn Lombardo(The Barbara Ann Karmanos Cancer Institute), Stephani C. Wang, Anthony F. Shields(Wayne State University), Roderick C. Deaño(University of Wisconsin–Madison), Vikram Dhillon(Wayne State University), Philip Agop Philip(Wayne State University), Syed Mahmood(NewYork–Presbyterian Hospital)
Cited by 3
Related Papers
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Recommendations on the Use of <sup>18</sup>F-FDG PET in Oncology
|Journal of Nuclear Medicine|2008|1.1k
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
|Frontiers in Immunology|2022|373
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline
|Journal of Clinical Oncology|2022|125
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline
|Journal of Clinical Oncology|2022|116